Periodontal maintenance does not preclude the ensuing use of locally delivered antibiotics (LDA), as needed.

An ongoing trial of the antibody bamlanivimab—administered with remdesivir, an antiviral medication—on hospitalized COVID-19 patients has been halted by bamlanivimab’s manufacturer Eli Lilly. The decision was made to stop the trial after…

Whether activated charcoal can whiten teeth requires an understanding of the difference between the terms “whitening” and “bleaching,” as well as awareness of the current research and the position of the American Dental Association (ADA) on…

Even though they are at high risk of complications related to COVID-19, older adults are happier than younger people as the global pandemic continues on. The study, based out of Stanford University in Stanford, California, included 1,000…

A bleeding disorder is a condition in which the normal blood clotting process is interrupted due to a deficiency or defect of one or more of the clotting factors necessary to form a blood clot. A deficiency/defect of one or more clotting…

Phase 3 General Distribution Funding from the United States Department of Health and Human Services Provider Relief Fund is available to dental practices. Opening on October 5 and closing November 6, the funding is part of the Coronavirus…

Two peer-reviewed studies demonstrate a decrease in deaths among hospitalized patients with COVID-19 across the board, including older adults and those with comorbidities. One study looked at 5,000 hospitalized COVID-19 patients in New York…

A University of Michigan School of Dentistry survey found that oral health professionals are less afraid of COVID-19 than other healthcare providers and non-healthcare providers, even though their work is noted as high risk. The survey of…

A survey of European experts in oral and maxillofacial surgery found that 80% noted aerosol-generating procedures in the dental setting as high risk in the transmission of the novel coronavirus. More than 80% asserted that face protection…

The U.S. Food and Drug Administration (FDA) has approved the antiviral drug remdesivir (brand name Veklury, Gilead Sciences) for treating patients hospitalized with COVID-19. This is the first treatment for COVID-19 to receive FDA approval.…